DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
40	高安動脈炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04299971 (ClinicalTrials.gov)	March 1, 2020	5/3/2020	Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients	Randomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexate and Tofacitinib Based on the ECTA Cohort.	Takayasu Arteritis;Methotrexate;Inhibition;Treatment	Drug: Methotrexate Tablets;Drug: Tofacitinib tablet	Shanghai Zhongshan Hospital	NULL	Recruiting	14 Years	100 Years	All	130	Phase 4	China

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

March 1, 2020

5/3/2020

Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients

Randomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexate and Tofacitinib Based on the ECTA Cohort.

Takayasu Arteritis;Methotrexate;Inhibition;Treatment

Drug: Methotrexate Tablets;Drug: Tofacitinib tablet

Shanghai Zhongshan Hospital

NULL

Recruiting

14 Years

100 Years

All

130

Phase 4

China